9月 2023, <>
英文版
加利福尼亚州红木城,09年2023月31日(环球通讯社)--Soleno Therapeutics,Inc.(Soleno)(纳斯达克股票代码:SLNO)...查看全文
$Soleno Therapeutics(SLNO)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-002264 Act: 33 Size: 1 KB 网页链接
$Soleno Therapeutics(SLNO)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001193125-23-197745 Act: 33 Size: 370 KB 网页链接
$Soleno Therapeutics(SLNO)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001193125-23-191355 Act: 33 Size: 396 KB 网页链接
$Soleno Therapeutics(SLNO)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001193125-23-184587 Act: 34 Size: 8 MB 网页链接
$Soleno Therapeutics(SLNO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-23-013027 Size: 12 KB 网页链接
$Soleno Therapeutics(SLNO)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-23-161629 Act: 34 Size: 67 KB 网页链接
$Soleno Therapeutics(SLNO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-034680 Size: 7 KB 网页链接
$Soleno Therapeutics(SLNO)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-23-159942 Act: 33 Size: 19 KB 网页链接
$Soleno Therapeutics(SLNO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-23-012639 Size: 13 KB 网页链接
$Soleno Therapeutics(SLNO)$ SC 13D General statement of acquisition of beneficial ownership Accession Number: 0001213900-23-045092 Act: 34 Size: 84 KB 网页链接